NCT04200066 A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma Status WITHDRAWN Phase PHASE1
NCT04157478 Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma Status UNKNOWN Phase PHASE2
NCT04121455 Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04119674 Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT04105374 Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma Status WITHDRAWN Phase PHASE2/PHASE3
NCT04074785 Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6 Status TERMINATED Phase EARLY_PHASE1
NCT04049669 Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04047706 Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04047303 CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma Status TERMINATED Phase PHASE1
NCT04047264 Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions Status RECRUITING Phase NA
NCT04028479 The Registry of Oncology Outcomes Associated with Testing and Treatment Status COMPLETED Phase N/A
NCT04019262 Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04015700 Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04007185 Surgically Induced Neurological Deficits in Glioblastomas (SIND Study) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04006119 Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma Status TERMINATED Phase PHASE2